nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—PDGFRA—refractive error	0.8	1	CbGaD
Regorafenib—FGFR2—cornea—refractive error	0.0127	0.349	CbGeAlD
Regorafenib—Sorafenib—PDGFRA—refractive error	0.00519	1	CrCbGaD
Regorafenib—DDR2—eye—refractive error	0.00306	0.0843	CbGeAlD
Regorafenib—DDR2—retina—refractive error	0.00304	0.0835	CbGeAlD
Regorafenib—EPHX2—eye—refractive error	0.00207	0.0569	CbGeAlD
Regorafenib—EPHX2—retina—refractive error	0.00205	0.0564	CbGeAlD
Regorafenib—FLT4—eye—refractive error	0.00187	0.0513	CbGeAlD
Regorafenib—FGFR2—eye—refractive error	0.00157	0.0431	CbGeAlD
Regorafenib—FLT1—eye—refractive error	0.00145	0.0399	CbGeAlD
Regorafenib—RAF1—eye—refractive error	0.00144	0.0397	CbGeAlD
Regorafenib—FLT1—retina—refractive error	0.00144	0.0395	CbGeAlD
Regorafenib—KDR—eye—refractive error	0.00123	0.0337	CbGeAlD
Regorafenib—KDR—retina—refractive error	0.00122	0.0334	CbGeAlD
Regorafenib—PDGFRB—eye—refractive error	0.00106	0.0292	CbGeAlD
Regorafenib—ABL1—eye—refractive error	0.000946	0.026	CbGeAlD
Regorafenib—ABL1—retina—refractive error	0.000938	0.0258	CbGeAlD
Regorafenib—ABCB1—retina—refractive error	0.000292	0.00802	CbGeAlD
Regorafenib—FGFR2—Signaling Pathways—CER1—refractive error	4.79e-05	0.000303	CbGpPWpGaD
Regorafenib—PDGFRA—Focal Adhesion—PTEN—refractive error	4.78e-05	0.000303	CbGpPWpGaD
Regorafenib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	4.78e-05	0.000302	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	4.77e-05	0.000302	CbGpPWpGaD
Regorafenib—ABL1—EGF/EGFR Signaling Pathway—PTEN—refractive error	4.77e-05	0.000302	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	4.76e-05	0.000301	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—WNT10A—refractive error	4.74e-05	0.0003	CbGpPWpGaD
Regorafenib—KIT—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	4.74e-05	0.0003	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—WNT10A—refractive error	4.73e-05	0.0003	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—BMP2—refractive error	4.73e-05	0.0003	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—RDH5—refractive error	4.71e-05	0.000298	CbGpPWpGaD
Regorafenib—KIT—Disease—RPS27—refractive error	4.71e-05	0.000298	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TJP2—refractive error	4.7e-05	0.000298	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CER1—refractive error	4.7e-05	0.000298	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—RNF111—refractive error	4.7e-05	0.000298	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CTSC—refractive error	4.7e-05	0.000297	CbGpPWpGaD
Regorafenib—FGFR1—B Cell Activation—PTEN—refractive error	4.7e-05	0.000297	CbGpPWpGaD
Regorafenib—PDGFRA—B Cell Activation—PTEN—refractive error	4.68e-05	0.000297	CbGpPWpGaD
Regorafenib—RAF1—Downstream signaling of activated FGFR—PTEN—refractive error	4.66e-05	0.000295	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PLA2G16—refractive error	4.66e-05	0.000295	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PCCA—refractive error	4.66e-05	0.000295	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—COL9A1—refractive error	4.59e-05	0.000291	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB4—PTEN—refractive error	4.59e-05	0.000291	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—VANGL2—refractive error	4.59e-05	0.00029	CbGpPWpGaD
Regorafenib—PDGFRB—DAP12 interactions—PTEN—refractive error	4.56e-05	0.000289	CbGpPWpGaD
Regorafenib—PDGFRB—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	4.56e-05	0.000289	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by FGFR in disease—PTEN—refractive error	4.56e-05	0.000289	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR—PTEN—refractive error	4.52e-05	0.000286	CbGpPWpGaD
Regorafenib—FGFR1—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	4.49e-05	0.000285	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—PDGFRA—refractive error	4.49e-05	0.000284	CbGpPWpGaD
Regorafenib—PDGFRA—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	4.48e-05	0.000284	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR in Cancer—PTEN—refractive error	4.48e-05	0.000284	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AXL—refractive error	4.47e-05	0.000283	CbGpPWpGaD
Regorafenib—FGFR1—Disease—RPS27—refractive error	4.47e-05	0.000283	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—RNF111—refractive error	4.46e-05	0.000282	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CER1—refractive error	4.46e-05	0.000282	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TJP2—refractive error	4.46e-05	0.000282	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by PDGF—PTEN—refractive error	4.46e-05	0.000282	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—RPS27—refractive error	4.46e-05	0.000282	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TJP2—refractive error	4.45e-05	0.000282	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CER1—refractive error	4.45e-05	0.000282	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—RNF111—refractive error	4.45e-05	0.000282	CbGpPWpGaD
Regorafenib—RAF1—Disease—LUM—refractive error	4.42e-05	0.00028	CbGpPWpGaD
Regorafenib—RAF1—Insulin Signaling—PTEN—refractive error	4.41e-05	0.000279	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—PML—refractive error	4.39e-05	0.000278	CbGpPWpGaD
Regorafenib—RAF1—Downstream signal transduction—PTEN—refractive error	4.38e-05	0.000278	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR—PTEN—refractive error	4.36e-05	0.000276	CbGpPWpGaD
Regorafenib—RAF1—EGF/EGFR Signaling Pathway—PTEN—refractive error	4.36e-05	0.000276	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB2—PTEN—refractive error	4.34e-05	0.000275	CbGpPWpGaD
Regorafenib—RAF1—DAP12 signaling—PTEN—refractive error	4.32e-05	0.000273	CbGpPWpGaD
Regorafenib—PDGFRB—Focal Adhesion—PTEN—refractive error	4.31e-05	0.000273	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—EBP—refractive error	4.28e-05	0.000271	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—WNT10A—refractive error	4.26e-05	0.00027	CbGpPWpGaD
Regorafenib—PDGFRB—B Cell Activation—PTEN—refractive error	4.22e-05	0.000267	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	4.18e-05	0.000265	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—PDGFRA—refractive error	4.12e-05	0.000261	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—VANGL2—refractive error	4.09e-05	0.000259	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR in disease—PTEN—refractive error	4.06e-05	0.000257	CbGpPWpGaD
Regorafenib—RAF1—DAP12 interactions—PTEN—refractive error	4.06e-05	0.000257	CbGpPWpGaD
Regorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	4.06e-05	0.000257	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—PDGFRA—refractive error	4.05e-05	0.000256	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—PTEN—refractive error	4.04e-05	0.000256	CbGpPWpGaD
Regorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	4.04e-05	0.000256	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PML—refractive error	4.03e-05	0.000255	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR—PTEN—refractive error	4.03e-05	0.000255	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—RPS27—refractive error	4.01e-05	0.000254	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CER1—refractive error	4.01e-05	0.000254	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—RNF111—refractive error	4.01e-05	0.000254	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TJP2—refractive error	4.01e-05	0.000254	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—PTEN—refractive error	4e-05	0.000253	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR in Cancer—PTEN—refractive error	3.99e-05	0.000253	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—PTEN—refractive error	3.97e-05	0.000252	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—PDGFRA—refractive error	3.96e-05	0.000251	CbGpPWpGaD
Regorafenib—KIT—Immune System—PML—refractive error	3.96e-05	0.000251	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—PDGFRA—refractive error	3.96e-05	0.00025	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—COL9A1—refractive error	3.95e-05	0.00025	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—COL9A1—refractive error	3.91e-05	0.000248	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—PDGFRA—refractive error	3.89e-05	0.000246	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—PDGFRA—refractive error	3.84e-05	0.000243	CbGpPWpGaD
Regorafenib—RAF1—Focal Adhesion—PTEN—refractive error	3.84e-05	0.000243	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—DSE—refractive error	3.83e-05	0.000243	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	3.82e-05	0.000242	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—EBP—refractive error	3.82e-05	0.000242	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—LUM—refractive error	3.81e-05	0.000241	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—LUM—refractive error	3.81e-05	0.000241	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—WNT10A—refractive error	3.8e-05	0.000241	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PML—refractive error	3.76e-05	0.000238	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PML—refractive error	3.75e-05	0.000237	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—EBP—refractive error	3.73e-05	0.000236	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—PTEN—refractive error	3.71e-05	0.000235	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—PDGFRA—refractive error	3.69e-05	0.000233	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CACNA1D—refractive error	3.67e-05	0.000232	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CACNA1D—refractive error	3.67e-05	0.000232	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—PTEN—refractive error	3.64e-05	0.000231	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—COL9A1—refractive error	3.63e-05	0.00023	CbGpPWpGaD
Regorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	3.6e-05	0.000228	CbGpPWpGaD
Regorafenib—RAF1—Disease—RPS27—refractive error	3.58e-05	0.000227	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—RNF111—refractive error	3.57e-05	0.000226	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CER1—refractive error	3.57e-05	0.000226	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TJP2—refractive error	3.57e-05	0.000226	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—COL9A1—refractive error	3.56e-05	0.000226	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	3.51e-05	0.000222	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—EBP—refractive error	3.49e-05	0.000221	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—PTEN—refractive error	3.46e-05	0.000219	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—PDGFRA—refractive error	3.45e-05	0.000218	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—PTEN—refractive error	3.45e-05	0.000218	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PLA2G16—refractive error	3.42e-05	0.000216	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PCCA—refractive error	3.42e-05	0.000216	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—COL9A1—refractive error	3.38e-05	0.000214	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PML—refractive error	3.38e-05	0.000214	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—COL9A1—refractive error	3.37e-05	0.000213	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—PDGFRA—refractive error	3.36e-05	0.000213	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—BMP2—refractive error	3.33e-05	0.000211	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—PDGFRA—refractive error	3.31e-05	0.00021	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PML—refractive error	3.29e-05	0.000208	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—DSE—refractive error	3.25e-05	0.000206	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CYP26A1—refractive error	3.24e-05	0.000205	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CYP26A1—refractive error	3.24e-05	0.000205	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—LUM—refractive error	3.23e-05	0.000205	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—BMP2—refractive error	3.15e-05	0.000199	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CACNA1D—refractive error	3.11e-05	0.000197	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—PTEN—refractive error	3.11e-05	0.000197	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—PDGFRA—refractive error	3.08e-05	0.000195	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—COL9A1—refractive error	3.04e-05	0.000192	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PML—refractive error	3.01e-05	0.00019	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—PDGFRA—refractive error	2.95e-05	0.000187	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—PDGFRA—refractive error	2.95e-05	0.000187	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—TUBB3—refractive error	2.95e-05	0.000187	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—DSE—refractive error	2.9e-05	0.000183	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PCCA—refractive error	2.89e-05	0.000183	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PLA2G16—refractive error	2.89e-05	0.000183	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—DSE—refractive error	2.83e-05	0.000179	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—PTEN—refractive error	2.77e-05	0.000175	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CYP26A1—refractive error	2.75e-05	0.000174	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—BMP2—refractive error	2.71e-05	0.000171	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—COL9A1—refractive error	2.71e-05	0.000171	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—BMP2—refractive error	2.68e-05	0.00017	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—DSE—refractive error	2.64e-05	0.000167	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—PDGFRA—refractive error	2.61e-05	0.000165	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PLA2G16—refractive error	2.58e-05	0.000163	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PCCA—refractive error	2.58e-05	0.000163	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PLA2G16—refractive error	2.52e-05	0.00016	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PCCA—refractive error	2.52e-05	0.00016	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—BMP2—refractive error	2.49e-05	0.000157	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—PTEN—refractive error	2.47e-05	0.000156	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—BMP2—refractive error	2.44e-05	0.000155	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PDGFRA—refractive error	2.4e-05	0.000152	CbGpPWpGaD
Regorafenib—BRAF—Disease—PDGFRA—refractive error	2.39e-05	0.000151	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—LUM—refractive error	2.37e-05	0.00015	CbGpPWpGaD
Regorafenib—KIT—Immune System—PDGFRA—refractive error	2.36e-05	0.000149	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PCCA—refractive error	2.35e-05	0.000149	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PLA2G16—refractive error	2.35e-05	0.000149	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—BMP2—refractive error	2.32e-05	0.000147	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—BMP2—refractive error	2.31e-05	0.000146	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—PTEN—refractive error	2.3e-05	0.000146	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—EBP—refractive error	2.3e-05	0.000146	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CACNA1D—refractive error	2.28e-05	0.000144	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PDGFRA—refractive error	2.24e-05	0.000142	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PDGFRA—refractive error	2.22e-05	0.00014	CbGpPWpGaD
Regorafenib—KIT—Disease—PDGFRA—refractive error	2.18e-05	0.000138	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—PTEN—refractive error	2.12e-05	0.000134	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—BMP2—refractive error	2.08e-05	0.000132	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PDGFRA—refractive error	2.08e-05	0.000132	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—PTEN—refractive error	2.08e-05	0.000132	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PDGFRA—refractive error	2.07e-05	0.000131	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—PTEN—refractive error	2.03e-05	0.000129	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—PTEN—refractive error	2.03e-05	0.000129	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CYP26A1—refractive error	2.01e-05	0.000128	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PDGFRA—refractive error	2.01e-05	0.000127	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—LUM—refractive error	2.01e-05	0.000127	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—PTEN—refractive error	1.99e-05	0.000126	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—PTEN—refractive error	1.97e-05	0.000125	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—PTEN—refractive error	1.97e-05	0.000124	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PDGFRA—refractive error	1.97e-05	0.000124	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PDGFRA—refractive error	1.96e-05	0.000124	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CACNA1D—refractive error	1.93e-05	0.000122	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—PTEN—refractive error	1.89e-05	0.00012	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—PTEN—refractive error	1.89e-05	0.00012	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—BMP2—refractive error	1.86e-05	0.000117	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PDGFRA—refractive error	1.86e-05	0.000117	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	1.8e-05	0.000114	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PDGFRA—refractive error	1.79e-05	0.000113	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—LUM—refractive error	1.79e-05	0.000113	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—PTEN—refractive error	1.77e-05	0.000112	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—LUM—refractive error	1.75e-05	0.000111	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DSE—refractive error	1.74e-05	0.00011	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—PTEN—refractive error	1.73e-05	0.000109	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CACNA1D—refractive error	1.72e-05	0.000109	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CYP26A1—refractive error	1.71e-05	0.000108	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—PTEN—refractive error	1.7e-05	0.000108	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PDGFRA—refractive error	1.69e-05	0.000107	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CACNA1D—refractive error	1.68e-05	0.000106	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PDGFRA—refractive error	1.67e-05	0.000106	CbGpPWpGaD
Regorafenib—RAF1—Disease—PDGFRA—refractive error	1.65e-05	0.000105	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—refractive error	1.64e-05	0.000104	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—LUM—refractive error	1.63e-05	0.000103	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—PTEN—refractive error	1.58e-05	0.0001	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CACNA1D—refractive error	1.57e-05	9.95e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PLA2G16—refractive error	1.55e-05	9.83e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PCCA—refractive error	1.55e-05	9.83e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PDGFRA—refractive error	1.55e-05	9.82e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PDGFRA—refractive error	1.52e-05	9.65e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CYP26A1—refractive error	1.52e-05	9.64e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—PTEN—refractive error	1.52e-05	9.6e-05	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—PTEN—refractive error	1.52e-05	9.6e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CYP26A1—refractive error	1.49e-05	9.4e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PDGFRA—refractive error	1.45e-05	9.16e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CYP26A1—refractive error	1.39e-05	8.79e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—PTEN—refractive error	1.34e-05	8.5e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PDGFRA—refractive error	1.3e-05	8.23e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PTEN—refractive error	1.23e-05	7.8e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—PTEN—refractive error	1.23e-05	7.77e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—PTEN—refractive error	1.21e-05	7.66e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PDGFRA—refractive error	1.16e-05	7.33e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PTEN—refractive error	1.15e-05	7.27e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PTEN—refractive error	1.15e-05	7.25e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PTEN—refractive error	1.14e-05	7.2e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—PTEN—refractive error	1.12e-05	7.07e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—LUM—refractive error	1.08e-05	6.81e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PTEN—refractive error	1.07e-05	6.76e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PTEN—refractive error	1.06e-05	6.71e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PTEN—refractive error	1.06e-05	6.69e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CACNA1D—refractive error	1.04e-05	6.56e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PTEN—refractive error	1.03e-05	6.53e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PTEN—refractive error	1.01e-05	6.39e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PTEN—refractive error	1.01e-05	6.37e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTEN—refractive error	9.53e-06	6.03e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PTEN—refractive error	9.2e-06	5.82e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP26A1—refractive error	9.15e-06	5.79e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PTEN—refractive error	8.68e-06	5.49e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—refractive error	8.64e-06	5.47e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PTEN—refractive error	8.59e-06	5.44e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTEN—refractive error	8.49e-06	5.38e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PTEN—refractive error	7.97e-06	5.04e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PTEN—refractive error	7.82e-06	4.95e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—refractive error	7.71e-06	4.88e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PTEN—refractive error	7.42e-06	4.7e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PTEN—refractive error	7.41e-06	4.69e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTEN—refractive error	7.31e-06	4.63e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTEN—refractive error	7.31e-06	4.63e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—refractive error	7.03e-06	4.45e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PTEN—refractive error	6.67e-06	4.22e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTEN—refractive error	6.2e-06	3.93e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PTEN—refractive error	5.95e-06	3.76e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTEN—refractive error	4.55e-06	2.88e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTEN—refractive error	3.85e-06	2.44e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTEN—refractive error	3.44e-06	2.18e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTEN—refractive error	3.35e-06	2.12e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTEN—refractive error	3.13e-06	1.98e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTEN—refractive error	2.07e-06	1.31e-05	CbGpPWpGaD
